Open Access

Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review

Vassiliki Tarara

Vassiliki Tarara

Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, School of MedicineThessaloniki, Greece
Search for this author on
Sciendo|Google Scholar
Tarara, Vassiliki
 and 
Evangelos Karamitrousis

Evangelos Karamitrousis

Medical Oncology Department, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General HospitalThessaloniki, Greece
Search for this author on
Sciendo|Google Scholar
Karamitrousis, Evangelos
  
Jul 12, 2025
Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: Jul 12, 2025
Received: Oct 06, 2024
Accepted: Dec 23, 2024
DOI: https://doi.org/10.2478/fco-2024-0007
Keywords
© 2025 Vassiliki Tarara et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Tarara, Vassiliki
Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, School of MedicineThessaloniki, Greece
Karamitrousis, Evangelos
Medical Oncology Department, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General HospitalThessaloniki, Greece
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology
Journal RSS Feed